A robust gene signature for the prediction of early relapse in stage I–III colon cancer

Colon cancer patients experiencing early relapse consistently exhibited poor survival. The aim of our study was to develop an mRNA signature that can help to detect early relapse cases in stage I–III colon cancer. Public microarray datasets of stage I–III colon cancer samples were extracted from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Weixing, Li, Yaqi, Mo, Shaobo, Feng, Yang, Zhang, Long, Xu, Ye, Li, Qingguo, Cai, Guoxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891048/
https://www.ncbi.nlm.nih.gov/pubmed/29377588
http://dx.doi.org/10.1002/1878-0261.12175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891048/
https://www.ncbi.nlm.nih.gov/pubmed/29377588
http://dx.doi.org/10.1002/1878-0261.12175

Ejemplares similares